Vidhi Specialty Food Ingredients Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹137 Cr +82.7% YoYSee revenue, profit and what management said. You are viewing Q3 FY25.
VS

Vidhi Specialty Food Ingredients Ltd

Q3 FY25Chemicals & Petrochemicals

Vidhi Specialty Food Ingredients Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹99Cr
+57.1% YoY
+8.8% QoQ
Net profit
₹13Cr
+44.4% YoY
+30% QoQ
Margin
19%
−4 pp YoY
+2 pp QoQ

Based on Vidhi Specialty Food Ingredients Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹352
Market cap₹1.7K Cr
P/E32.1

The short version

Q3 FY25 Revenue from Operations: Rs. 98.5 Crs. Q3 FY25 EBITDA: Rs. 19.0 Crs, up 31.8% YoY (from Rs. 14.4 Crs in Q3 FY24).

From Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q3 FY25 Revenue from Operations: Rs. 98.5 Crs
  • Q3 FY24 Revenue from Operations: Rs. 63.0 Crs
  • Year-on-Year (Y-o-Y) Growth: 56.5% increase
  • 9MFY25 Revenue: Rs. 272.8 Crs vs Rs. 222.8 Crs in 9MFY24 (22.4% Y-o-Y growth)

2 more points from Vidhi Specialty Food Ingredients Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Vidhi Specialty Food Ingredients Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Dahej SEZ Plant (Phase-I)
  • Capacity added: 350 MT per month, increasing total to 675 MT
  • Commercial production commenced December 12, 2023 (trial started August 27, 2023)
  • Investment: INR 70 Crs funded through internal accruals
  • Status: Operational with some teething issues; expected to run at optimal capacity before financial year-end
  • Roha MIDC Plant (Phase-II) - Arjun Foods (wholly-owned subsidiary)
  • Planned capacity addition: 360 MT per month (180 MT per phase)
  • Environmental clearance applied
  • Location: 200 meters from current Roha manufacturing site
  • Expected timeline: 2025-26
  • Overall Capacity Expansion Plan

2 more points from Vidhi Specialty Food Ingredients Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vidhi Specialty Food Ingredients Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Vidhi Specialty Food Ingredients Ltd said on order book & pipeline — free account, 30 seconds.

Vidhi Specialty Food Ingredients Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Vidhi Specialty Food Ingredients Ltd Q3 FY25 results — key figures

Vidhi Specialty Food Ingredients Ltd Q3 FY25 reported results vs Q3 FY24, ₹ crore
₹ CrQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue9963+57.1%91+8.8%
Operating profit (EBITDA)1914+35.7%15+26.7%
Operating margin19%23%-4 pp17%+2 pp
Profit before tax1712+41.7%14+21.4%
Net profit (PAT)139+44.4%10+30%
EPS (₹)2.541.71+48.5%2.08+22.1%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹137 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q3 FY25)

    1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Gujarat Alkalies (Q3 FY25)

    3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Balaji Amines (Q3 FY25)

    Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…

  • Chemcon Speciality Chemicals (Q3 FY25)

    54.4 Cr, up 3% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vidhi Specialty Food Ingredients Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vidhi Specialty Food Ingredients Ltd Q3 FY25 results?

Q3 FY25 Revenue from Operations: Rs. 98.5 Crs. Q3 FY25 EBITDA: Rs. 19.0 Crs, up 31.8% YoY (from Rs. 14.4 Crs in Q3 FY24).

What is Vidhi Specialty Food Ingredients Ltd share price analysis?

Vidhi Specialty Food Ingredients Ltd currently shows a neutral. The stock trades at a P/E of 32.1 with a market cap of ₹1,721 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vidhi Specialty Food Ingredients Ltd planning capital expenditure?

Dahej SEZ Plant (Phase-I) - Capacity added: 350 MT per month, increasing total to 675 MT - Commercial production commenced December 12, 2023 (trial started August 27, 2023) - Investment:

Keep Vidhi Specialty Food Ingredients Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.